Anumigilimab

Names

[ CAS No. ]:
2416593-08-1

[ Name ]:
Anumigilimab

Biological Activity

[Description]:

Anumigilimab (CSL-324) is an humanized IgG2a mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation[1][2].

[Related Catalog]:

Research Areas >> Inflammation/Immunology
Signaling Pathways >> Protein Tyrosine Kinase/RTK >> c-Fms

[Target]

granulocyte colony-stimulating factor (G-CSF) receptor[1]


[References]

[1]. Markota Čagalj A, et al. New and Emerging Targeted Therapies for Hidradenitis Suppurativa. Int J Mol Sci. 2022 Mar 29;23(7):3753.  

[2]. Rosales Santillan M, et al. Biologic therapies for the treatment of hidradenitis suppurativa. Expert Opin Biol Ther. 2020 Jun;20(6):621-633.  

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds